Prolonged oxidative stress impairs insulin-induced GLUT4 translocation in 3T3-L1 adipocytes

Diabetes

Volumn 47, Issue 10, 1998, Pages 1562-1569

  Rudich, Assaf ^a   Tlrosh, Amir ^a   Potashnik, Ruth ^a   Hemi, Rina ^b   Kanety, Hannah ^b   Bashan, Nava ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE OXIDASE; GLUCOSE TRANSPORTER; HYDROGEN PEROXIDE; INSULIN; PHOSPHATIDYLINOSITOL KINASE;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CONTROLLED STUDY; ENZYME ACTIVATION; GLUCOSE TRANSPORT; INSULIN RESISTANCE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; 3T3 CELLS; ADIPOCYTES; ANIMALS; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 4; HYDROGEN PEROXIDE; INSULIN; MICE; MICROSOMES; MONOSACCHARIDE TRANSPORT PROTEINS; MUSCLE PROTEINS; OSMOLAR CONCENTRATION; OXIDATIVE STRESS; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 0031683542     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1562     Document Type: Article

References (55)

1. Flakoll P, Carlson MG, Cherrington A: Physiological action of insulin. In Diabetes Mellitus. LeRoith D, Taylor SI, Olefsky JM, Eds. New York, Lippincott-Raven, 1996, p. 121-132
2. Abel ED, Shepherd PR, Kahn BB: Glucose transporters and pathophysiologic states. In Diabetes Mellitus. LeRoith D, Taylor SI, Olefsky JM, Eds. New York, Lippincott-Raven, 1996, p. 530-543
3. Baynes JW: Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412, 1991
4. Wolff SP, Jiang ZY, Hunt JV: Protein glycation and oxidative stress in diabetes mellitus and aging. Free Radic Biol Med 10:339-352, 1991
5. Jones AF, Winkles JW, Jennings PE, Florkowski CM, Lunec J, Barnett AH: Serum antioxidant activity in diabetes mellitus. Diabetes Res 7:89-92, 1988
6. Nourooz Zadeh J, Tajaddini Sarmadi J, McCarthy S, Berteridge DJ, Wolff SP: Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44:1054-1058, 1995
7. Yan SD, Schmidt AM, Anderson GM, Zhang J, Brett J, Zou YS, Pinsky D, Stern D: Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J Biol Chem 269:9889-9897, 1994
8. Paolisso G, D'Amore A, Volpe C, Balbi V, Saccomanno F, Glazerano D, Giugliano D, Varricchio M, D'Onofrio F: Evidence for a relationship between oxidative stress and insulin action in non-insulin-dependent (type II) diabetic patients. Metabolism 43:1426-1429, 1994
9. Nacitarhan S, Ozben T, Tuncer N: Serum and urine malondialdehyde levels in NIDDM patients with and without hyperlipidemia. Free Radic Biol Med 19:893-896, 1995
10. Dandona P, Thusu K, Cook S, Snyder B, Makowski J, Armstrong D, Nicotera T: Oxidative damage to DNA in diabetes mellitus. Lancet 347:444-445, 1996
11. Griesmacher A, Kindhauser M, Andert SE, Schreiner W, Toma C, Knoebl P, Prager R, Schnack C, Schernthaner G: Enhanced serum levels of thiobarbituric-acid-reactive substances in diabetes mellitus. Am J Med 98:469-475, 1995
12. Giugliano D, Ceriello A, Paolisso G: Oxidative stress and diabetic vascular complications. Diabetes Care 19:257-267, 1996
13. Schmidt AM, Hon O, Brett J, Yan SD, Wautier JL, Stern D: Cellular receptors for advanced glycation end products: implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb Vase Biol 14:1521-1528, 1994
14. Paolisso G, Giugliano D: Oxidative stress and insulin action: is there a relationship? Diabetologia 39:357-363, 1996
15. Cominacini L, Garbin U, Lo Cascio V: The need for a "free radical initiative" (Comment). Diabetologia 39:364-366, 1996
16. Nourooz-Zadeh J, Rahimi A, Tajaddini-Sarmadi J, Tritschler H, Rosen P, Halliwell B, Betteridge DJ: Relationship between plasma measures of oxidative stress and metabolic control in NIDDM. Diabetologia 40:647-653, 1997
17. Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ: Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoic acid. Arzneimittelforschung 45:872-874, 1995
18. Caballero B: Vitamin E improves the action of insulin. Nutr Rev 51:339-340, 1993
19. Hadari Y, Tzahar E, Nadiv O, Rothenberg P, Roberts CT Jr, LeRoith D, Yarden Y, Zick Y: Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3-kinase upon its association with pp 185 (IRS-1) in intact rat livers. J Biol Chem 267:17483-17486, 1992
20. Hayes GR, Lockwood DH: Role of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide. Proc Natl Acad Sci U S A 84:8115-8119, 1987
21. 2 and vanadate stimulate protein tyrosine phosphorylation in intact cells. J Biol Chem 265:2896-2902, 1990
22. 2 and vanadate enhances insulin receptor mediated tyrosine phosphorylation of IRS- 1 leading to IRS-1 association with the phosphatidylinositol 3-kinase. J Cell Biochem 58:279-291, 1995
23. Ricort JM, Tanti JF, Van Obberghen E, Le Marchand Brustel Y: Alterations in insulin signalling pathway induced by prolonged insulin treatment of 3T3-L1 adipocytes. Diabetologia 38:1148-1156, 1995
24. Torojman KM, Leingang KA, James DE, Mueckler MM: Differential regulation of two distinct glucose transporter species expressed in 3T3-L1 adipocytes: effect of chronic insulin and tolbutamide treatment. Proc Natl Acad Sci U S A 86:7761-7765, 1989
25. Kozka IJ, Clark AE, Holman GD: Chronic treatment with insulin selectively down-regulates cell-surface GLUT4 glucose transporters in 3T3-L1 adipocytes. J Biol Chem 266:11726-11731, 1991
26. Rudich A, Kozlovsky N, Potashnik R, Bahan N: Oxidant stress reduces insulin responsiveness in 3T3-L1 adipocytes. Am J Physiol 272:E935-E940, 1997
27. Kozlovsky N, Rudich A, Potashnik A, Bashan N: Reactive oxygen species activate glucose transport in L6 myotubes. Free Radic Biol Med 23:859-869, 1997
28. Kozlovsky N, Rudich A, Potashnik R, Ebina Y, Murakami T, Bashan N: Transcriptional activation of the GLUT1 gene in response to oxidative stress in L6 myotubes. J Biol Chem 272:33367-33372, 1997
29. Slein MW: D-glucose: determination with hexokinase and glucose-6-phosphate dehydrogenase. In Methods of Enzymatic Analysis. Bergmeyer HU, Ed. New York, London, Verlag Chemie, 1965, p. 117-123
30. Clancy BM, Czech MP: Hexose transport stimulation and membrane redistribution of glucose transporter isoforms in response to cholera toxin, dibutyryl cyclic AMP, and insulin in 3T3-L1 adipocytes. J Biol Chem 265:12434-12443, 1990
31. Kanety H, Feinstein R, Papa MZ, Hemi R, Karasik A: Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem 270:23780-23784, 1995
32. Sargeant RJ, Paquet MR: Effect of insulin on the rates of synthesis and degradation of GLUT1 and GLUT4 glucose transporters in 3T3-L1 adipocytes. Biochem J 290:913-919, 1993
33. Clancy BM, Harrison SA, Buxton JM, Czech MP: Protein synthesis inhibitors activate glucose transport without increasing plasma membrane glucose transporters in 3T3-L1 adipocytes. J Biol Chem 266:10122-10130, 1991
34. Chen D, Elmendorf JS, Olson AL, Li X, Earp HS, Pessin JE: Osmotic shock stimulates GLUT4 translocation in 3T3-L1 adipocytes by a novel kinase pathway. J Biol Chem 272:27401-27410, 1997
35. Holman GD, Kasuga M: From receptor to transporter: insulin signalling to glucose transport. Diabetologia 40:991-1003, 1997
36. Nave BT, Haigh RJ, Hayward AC, Siddle K, Shepherd PR: Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem J 318:55-60, 1996
37. Ricort JM, Tanti JF, Van Obberghen E, Le Marchand Brustel Y: Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes: a possible explanation for their specific effects on glucose transport. Eur J Biochem 239:17-22, 1996
38. Heller Harrison RA, Morin M, Guilherme A, Czech MP: Insulin-mediated targeting of phosphatidylinositol 3-kinase to GLUT4-containing vesicles. J Biol Chem 271:10200-10204, 1996
39. Frevert EU, Kahn BB: Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol 17:190-198, 1997
40. Henriksen EJ, Holloszy JO: Effects of phenylarsine oxide on stimulation of glucose transport in rat skeletal muscle. Am J Physiol 258:C648-C653, 1990
41. Fischer Y, Rose H, Thomas J, Deuticke B, Kammermeier H: Phenylarsine oxide and hydrogen peroxide stimulate glucose transport via different pathways in isolated cardiac myocytes. Biochim Biophys Acta 1153:97-104, 1993
42. Frost SC, Lane MD: Evidence for the involvement of vicinal sulfhydryl groups in insulin-activated hexose transport by 3T3-L1 adipocytes. J Biol Chem 260:2646-2652, 1985
43. Sowell MO, Robinson KA, Buse MG: Phenylarsine oxide and denervation effects on hormone-stimulated glucose transport. Am J Physiol 255:E159-E165, 1988
44. Begum N: Phenyarsine oxide inhibits insulin-stimulated protein phosphatase 1 activity and GLUT4 translocation. Am J Physiol 267:E14-E23, 1994
45. Rothman JE, Warren G: Implications of the SNARE hypothesis for intracellular membrane topology and dynamics. Curr Biol 4:220-233, 1994
46. Schnitzer JE, Allard J, Oh P: NEM inhibits transcytosis, endocytosis, and capillary permeability: implication of caveolae fusion in endothelia. Am J Physiol 268:H48-H55, 1995
47. Rea S, James DE: Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes 46:1667-1677, 1997
48. Holman GD, Lo Leggio L, Cushman SW: Insulin-stimulated GLUT4 glucose transporter recycling: a problem in membrane protein subcellular trafficking through multiple pools. J Biol Chem 269:17516-17524, 1994
49. Chen HC, Guan JL: Stimulation of phosphatidylinositol 3′-kinase association with focal adhesion kinase by platelet-derived growth factor. J Biol Chem 269:31229-31233, 1994
50. Saito Y, Mon S, Yokote K, Kanzaki T, Saito Y, Morisaki N: Phosphatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor. Biochem Biophys Res Commun 224:23-26, 1996
51. Guinebault C, Payrastre B, Racaud Sultan C, Mazarguil H, Breton M, Mauco G, Plantavid M, Chap H: Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol 129:831-842, 1995
52. Piper RC, Hess LJ, James DE: Differential sorting of two glucose transporters expressed in insulin-sensitive cells. Am J Physiol 260:C570-C580, 1991
53. Zorzano A, Wilkinson W, Kotliar N, Thoidis G, Wadzinkski BE, Ruoho AE, Pilch PF: Insulin-regulated glucose uptake in rat adipocytes is mediated by two transporter isoforms present in at least two vesicle populations. J Biol Chem 264:12358-12363, 1989
54. Richardson JM, Balon TW, Treadway JL, Pessin JE: Differential regulation of glucose transporter activity and expression in red and white skeletal muscle. J Biol Chem 266:12690-12694, 1991
55. Yang J, Holman GD: Comparison of GLUT4 and GLUT1 subcelluar trafficking in basal and insulin-stimulated 3T3-L1 cells. J Biol Chem 268:4600-4603, 1993